Director/PDMR Shareholding

RNS Number : 2774U
Dechra Pharmaceuticals PLC
19 December 2011
 



Dechra Pharmaceuticals PLC 

("the Company")

 Directors / PDMR Share Dealing

 

19 December 2011

 

Dechra Pharmaceuticals PLC announces the following:

 

Exercise of LTIP options:

 

On 16 December 2011, the following Directors exercised options over ordinary shares of 1p each in the Company, granted to them on 19 November 2008 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP): 

 

Name

Capacity

Options Exercised

Shares Sold

Sale Price

per share

 

Total beneficial shareholding following this announcement

Percentage of issued share capital

Ian Page

Director

65,842

34,167

£5.0004

757,955

 

1.135%

Simon Evans

Director

41,386

0

0

924,075

1.384%

Edwin Torr

Director

39,505

39,505

£5.0004

412,500

0.618%

Zoe Goulding

PDMR

3,762

1,953

£5.0004

4,299

0.006%

 

The exercise of the LTIP options were subject to the achievement of performance conditions which vested at 71.11% of the total award.

 

All Directors (other than Simon Evans) and the PDMR have sold sufficient shares (acquired pursuant to the LTIP exercise) in order to fund the resulting tax liability.  

 

 

For further information

 

Zoe Goulding, Company Secretary            

Telephone number: 01782 771100

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDKCDPABDDNBD
UK 100

Latest directors dealings